Close

Drug Research

VentiRx, Celgene to develop cancer drug

  VentiRx Pharmaceuticals has formed a world-wide collaboration with Celgene Corporation to develop VTX-2337, a highly potent and selective TLR8 agonist for cancer treatment. ...

Atreca uses Immune Repertoire Capture technology to develop new...

Atreca and Bill & Melinda Gates Foundation have collaborated to accelerate the discovery and development of new vaccines and therapeutics for human infectious diseases...

US FDA approves Mylan Valsartan and Hydrochlorothiazide tablets

Mylan Pharmaceuticals, a subsidiary of Mylan, has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application...

Transgenomic to advance pancreatic cancer research with NIH grant

Transgenomic, a global biotechnology company, has won $100,000 small business technology transfer programme (STTR) Phase I grant from National Institutes of Health's (NIH) National...

US FDA approves Wockhardt hypertension drug

Wockhardt has received final approval from the US Food and Drug Administration ((FDA) to market extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine, which...

RayBiotech screening assays used to identify chemoresistance pathway

RayBiotech-developed antibody-based biomarker screening assays have been used to identify a critical pathway involved in chemotherapeutic resistance acquired by melanoma cancer cells. ...

Elsevier integrates Reaxys with electronic laboratory notebook

PerkinElmer has integrated its electronic laboratory notebook (ELN) with Elsevier's Reaxys, a web-based workflow solution designed for chemistry researchers in drug discovery, chemicals and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read